Cargando…

Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells

BACKGROUND: Expression of CD44 receptor is associated with the onset of several tumors. The intracellular domain of CD44 (CD44-ICD) has been implicated as a co-transcription factor for RUNX2 in the regulation of expression of MMP-9 in breast carcinoma cells. Previous studies from our laboratory demo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Senbanjo, Linda T., AlJohani, Hanan, Majumdar, Sunipa, Chellaiah, Meenakshi A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647163/ https://www.ncbi.nlm.nih.gov/pubmed/31331331 http://dx.doi.org/10.1186/s12964-019-0395-6

Ejemplares similares

Identification of sequence-specific interactions of the CD44-intracellular domain with RUNX2 in the transcription of matrix metalloprotease-9 in human prostate cancer cells
por: Senbanjo, Linda T., et al.
Publicado: (2020)

Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2
por: Srinivasan, Deepa, et al.
Publicado: (2018)

C-phycocyanin attenuates RANKL-induced osteoclastogenesis and bone resorption in vitro through inhibiting ROS levels, NFATc1 and NF-κB activation
por: AlQranei, Mohammed S., et al.
Publicado: (2020)

Peptidomimetic inhibitor of L-plastin reduces osteoclastic bone resorption in aging female mice
por: Aljohani, Hanan, et al.
Publicado: (2021)

Peptidomimetic inhibitors of L-plastin reduce the resorptive activity of osteoclast but not the bone forming activity of osteoblasts in vitro
por: Chellaiah, Meenakshi A., et al.
Publicado: (2018)

CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells
por: Senbanjo, Linda T., et al.
Publicado: (2017)

Methylsulfonylmethane increases osteogenesis and regulates the mineralization of the matrix by transglutaminase 2 in SHED cells
por: Aljohani, Hanan, et al.
Publicado: (2019)

Engineering of L-Plastin Peptide-Loaded Biodegradable Nanoparticles for Sustained Delivery and Suppression of Osteoclast Function In Vitro
por: Majumdar, Sunipa, et al.
Publicado: (2019)

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
por: AlQranei, Mohammed S., et al.
Publicado: (2021)

Methylsulfonylmethane Increases the Alveolar Bone Density of Mandibles in Aging Female Mice
por: Aljohani, Hanan, et al.
Publicado: (2021)

L-Plastin deficiency produces increased trabecular bone due to attenuation of sealing ring formation and osteoclast dysfunction
por: Chellaiah, Meenakshi A., et al.
Publicado: (2020)

Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
por: Desai, Bhavik, et al.
Publicado: (2007)

Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis
por: Gupta, Aditi, et al.
Publicado: (2012)

Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells
por: Robertson, Brian W, et al.
Publicado: (2010)

Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells
por: Gupta, Aditi, et al.
Publicado: (2013)

Membrane Localization of Membrane Type 1 Matrix Metalloproteinase by CD44 Regulates the Activation of Pro-Matrix Metalloproteinase 9 in Osteoclasts
por: Chellaiah, Meenakshi A., et al.
Publicado: (2013)

Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway
por: Okamoto, Isamu, et al.
Publicado: (2001)

CD44 Intracellular Domain: A Long Tale of a Short Tail
por: Skandalis, Spyros S.
Publicado: (2023)

Aberrant DNA Methylation and Prostate Cancer
por: Majumdar, Sunipa, et al.
Publicado: (2011)

Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer
por: Cho, Yunhee, et al.
Publicado: (2015)

RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells
por: Yan, Xiaodong, et al.
Publicado: (2020)

A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid
Publicado: (1996)

RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis
por: Zhang, Hao, et al.
Publicado: (2023)

Inhibition of CD44 intracellular domain production suppresses bovine articular chondrocyte de-differentiation induced by excessive mechanical stress loading
por: Sobue, Yasumori, et al.
Publicado: (2019)

Interleukin‐4 induces a CD44(high)/CD49b(high) PC3 subpopulation with tumor‐initiating characteristics
por: Erb, Holger H.H., et al.
Publicado: (2018)

PC44. The Link Between Obesity and Migraine: Does This Exist?
por: Saffari, Tiam Mana, et al.
Publicado: (2023)

L-Plastin Phosphorylation: Possible Regulation by a TNFR1 Signaling Cascade in Osteoclasts
por: Chellaiah, Meenakshi A.
Publicado: (2021)

Evaluation of CD44 Expression in Prostatic Adenocarcinoma: An Institutional Study
por: Damarasingu, Priyanka V, et al.
Publicado: (2023)

Identification of hyaluronic acid binding sites in the extracellular domain of CD44
Publicado: (1993)

Promising Noninvasive Cellular Phenotype in Prostate Cancer Cells Knockdown of Matrix Metalloproteinase 9
por: Gupta, Aditi, et al.
Publicado: (2013)

Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin
Publicado: (1992)

Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain
Publicado: (1995)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

Runx2 stimulates neoangiogenesis through the Runt domain in melanoma
por: Cecconi, Daniela, et al.
Publicado: (2019)

Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells
por: Di Stefano, Chiara, et al.
Publicado: (2018)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
por: Montero-Montero, Lucía, et al.
Publicado: (2020)

The PcMYB44‐mediated miR397‐ PcLACs module regulates defence‐induced lignification in pear resistance to fungal disease
por: Yang, Yuekun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fbmscrs8ls6pmm2qt7pj03lf2l